BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26823834)

  • 1. Association of RNF43 with cell cycle proteins involved in p53 pathway.
    Xie H; Xing C; Cao G; Wei B; Xu X; Song P; Chen L; Chen H; Yin S; Zhou L; Zheng S
    Int J Clin Exp Pathol; 2015; 8(11):14995-5000. PubMed ID: 26823834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
    Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
    Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
    Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
    Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma.
    Xing C; Zhou W; Ding S; Xie H; Zhang W; Yang Z; Wei B; Chen K; Su R; Cheng J; Zheng S; Zhou L
    Mol Cancer Ther; 2013 Jan; 12(1):94-103. PubMed ID: 23136185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
    Azlin AH; Looi LM; Cheah PL
    Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF43 interacts with NEDL1 and regulates p53-mediated transcription.
    Shinada K; Tsukiyama T; Sho T; Okumura F; Asaka M; Hatakeyama S
    Biochem Biophys Res Commun; 2011 Jan; 404(1):143-7. PubMed ID: 21108931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
    Gorgoulis VG; Zacharatos P; Kotsinas A; Liloglou T; Kyroudi A; Veslemes M; Rassidakis A; Halazonetis TD; Field JK; Kittas C
    Am J Pathol; 1998 Dec; 153(6):1749-65. PubMed ID: 9846966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
    Choi YL; Park SH; Jang JJ; Park CK
    J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
    Dworakowska D; Jassem E; Jassem J; Karmoliński A; Lapiński M; Tomaszewski D; Rzyman W; Jaśkiewicz K; Sworczak K; Grossman AB
    Lung Cancer; 2009 Oct; 66(1):127-33. PubMed ID: 19200616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma--survival and clinical characteristics in relation to various histologic molecular markers in Western patients.
    Schöniger-Hekele M; Hänel S; Wrba F; Müller C
    Liver Int; 2005 Feb; 25(1):62-9. PubMed ID: 15698400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
    Jing Z; Nan KJ; Hu ML
    World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.
    Zhu Z; Lin J; Qu JH; Feitelson MA; Ni CR; Li FM; Zhu MH
    World J Gastroenterol; 2005 Apr; 11(13):1903-9. PubMed ID: 15800978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.